Merck Expands Covid-19 Antiviral Drug Production in Ontario
06 Dezembro 2021 - 01:39PM
Dow Jones News
By Adriano Marchese
Merck & Co. is set to expand its investigational antiviral
drug in the treatment against Covid-19 in a manufacturing agreement
with Thermo Fisher Scientific Inc.
In a statement on Monday, the pharmaceutical company said Thermo
Fisher will manufacture molnupiravir in its site in Whitby,
Ontario, for global distribution.
The news follows the signing of a supply agreement for the drug
with the Canadian government on Friday.
Write to Adriano Marchese at adriano.marchese@wsj.com
(END) Dow Jones Newswires
December 06, 2021 11:24 ET (16:24 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Thermo Fisher Scientific (NYSE:TMO)
Gráfico Histórico do Ativo
De Fev 2024 até Mar 2024
Thermo Fisher Scientific (NYSE:TMO)
Gráfico Histórico do Ativo
De Mar 2023 até Mar 2024